Georgia CaRes

奥古斯塔大学是格鲁吉亚唯一的NCI社区肿瘤学研究项目的所在地 少数民族/服务不足社区网站（NCORP M/U社区网站）自2014年以来。与DeKalb合作 医学中心，莫尔豪斯医学院，雅典大学血液和癌症中心，菲比 奥尔巴尼的普特尼医疗中心、奥古斯塔的奥古斯塔肿瘤协会和圣多米尼克-杰克逊 位于密西西比州杰克逊的纪念医院，格鲁吉亚州CaRes NCORP M/U研究中心已招募了408名患者 NCI临床试验，其中47%是非洲裔美国人和其他少数民族。本应用程序的主要目标 维持和发展我们的NCORP社区网站，专注于改善患者的治疗效果， 整个格鲁吉亚州及其他地区的M/U人口的健康差距。格鲁吉亚有一些 国家最严重的癌症差异。格鲁吉亚的非裔美国人的癌症经历与美国人的癌症经历有很大不同， 高加索人的死亡率尤其明显， 几种常见的癌症（例如，结肠直肠癌和乳腺癌）。我们最初的计划被恰当地命名为格鲁吉亚 CaRes（格鲁吉亚癌症研究），代表我们对癌症研究的共同承诺，包括 癌症控制、癌症预防和癌症护理提供方面的研究，以及NCI的临床试验， 国家临床试验网络（NCTN）。格鲁吉亚卡雷斯的续约将使我们能够继续服务 少数民族和医疗服务不足的人口高度集中的州的大片地区。我们将 通过以下具体目标实现这一目标：1）格鲁吉亚CaRes将促进参与， 将患者和医疗保健提供者纳入癌症控制、预防和癌症护理提供 研究（CCDR）的研究开发的NCI的研究基地和人体研究试验的国家 临床试验网络（NCTN）; 2）格鲁吉亚CaRes将通过改善和加强NCORP目标 我们作为NCORP M/U社区网站的活动范围;以及3）格鲁吉亚CaRes将增加 通过我们的NCORP M/U社区网络和研究基地的合作。重建格鲁吉亚 CaRes将对少数民族和服务不足人群的健康产生重大而深远的影响 在格鲁吉亚州及其他地区。

Augusta University has been home to Georgia's only NCI Community Oncology Research Program Minority/Underserved Community Site (NCORP M/U Community Site) since 2014. In partnership with DeKalb Medical Center, Morehouse School of Medicine, University Blood and Cancer Center in Athens, Phoebe Putney Medical Center in Albany, Augusta Oncology Associates in Augusta, and St. Dominic-Jackson Memorial Hospital in Jackson, Mississippi, the Georgia CaRes NCORP M/U Site has enrolled 408 patients to NCI clinical trials, 47% of which are African American and other minorities. The main goals of this application are to sustain and grow our NCORP Community Site, focusing on improving patient outcomes and reducing health disparities in M/U populations throughout the State of Georgia and beyond. Georgia has some of the nation's worst cancer disparities. The cancer experience for African Americans in Georgia varies widely from that of Caucasians and is especially evident in the disproportionate and astounding mortality rates from several common cancers (e.g., colorectal and breast cancers). Our original program was aptly named Georgia CaRes (Georgia Cancer Research) and represents our shared commitment to cancer research, including studies in cancer control, cancer prevention, and cancer care delivery, as well as clinical trials from NCI's National Clinical Trials Network (NCTN). The renewal of Georgia CaRes will allow us to continue to serve large regions of the state with high concentrations of minority and medically underserved populations. We will accomplish this through the following Specific Aims: 1) Georgia CaRes will facilitate participation and enrollment of patients and healthcare providers into cancer control, prevention, and cancer care delivery research (CCDR) studies developed by NCI's Research Bases and in human research trials of the National Clinical Trials Network (NCTN); 2) Georgia CaRes will support and strengthen NCORP goals by improving the scope of our activities as an NCORP M/U Community Site; and 3) Georgia CaRes will increase collaboration across our NCORP M/U Community network and with the Research Bases. Renewal of Georgia CaRes will have a significant and far-reaching impact on the health of minority and underserved populations within the State of Georgia and beyond.